This newest twist in the Lykos Therapeutics saga threatens A serious overhaul of the corporate’s strategy and way, with Musk ally and billionaire investor Antonio Gracias appearing to choose to get the corporate back again toward its nonprofit drug enhancement roots and a more Doblinite philosophy.The foodstuff allergy application was submitted v